Proceeding contribution from Anne Begg (Labour) in the House of Commons on Monday, 19 May 2008. It occurred during Debate on bill and Committee of the Whole House (HC) on Human Fertilisation and Embryology Bill [Lords].
Human Fertilisation and Embryology Bill [Lords]
One of the main cures that being developed is gene replacement therapy, which is particularly relevant for people with single gene defects. It involves the defective gene being replaced with one that is not defective. Does my hon. Friend think that science should not go down that route? If so, what is the difference between that technique being used once a child is born, and it being used before a child is born?
Secondary information
- Type
- Proceeding contribution
- Reference
- 476 c47
- Session
- 2007-08
- Chamber / Committee
- House of Commons chamber
- Subjects
- Children Clones Animals Congenital abnormalities Fertility Licensing Human embryo experiments Diseases Donors Genetics Human Fertilisation and Embryology Authority Ethics IVF Foetal tissue Medical treatments Relatives Research Stem cells Human-animal hybrid embryos
- Legislation
- Human Fertilisation and Embryology Bill (HL) 2007-08
- Link
- View this Proceeding contribution on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2023-12-16 01:41:01 +0000
- URI
- http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_474120
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_474120
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_474120